Phase 2 Delirium Clinical Trials
24 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 24 trials
Recruiting
Phase 2
Exogenous Ketone Supplementation in ICU Delirium
ICU deliriumCritical Illness
Vanderbilt University Medical Center40 enrolled1 locationNCT07364162
Recruiting
Phase 2
The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients
Emergence Delirium in Pediatric Anesthesia
Ain Shams University60 enrolled1 locationNCT07519863
Recruiting
Phase 2
Melatonin for Treatment of Delirium in Critically Ill Adult Patients
Delirium
Ciusss de L'Est de l'Île de Montréal30 enrolled1 locationNCT05713877
Recruiting
Phase 2
Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery
Delirium - Postoperative
Benha University75 enrolled1 locationNCT07443085
Recruiting
Phase 2
Daridorexant to Prevent Post-cardiotomy Delirium
Postoperative DeliriumPostoperative Cognitive Decline
University of Rochester80 enrolled1 locationNCT07217912
Recruiting
Phase 2Phase 3
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
DeliriumEpilepticsNeuroleptics
M.D. Anderson Cancer Center42 enrolled1 locationNCT05431595
Recruiting
Phase 2
The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study
Mild Cognitive ImpairmentPostoperative DeliriumPostoperative Cognitive Dysfunction
University of Michigan250 enrolled1 locationNCT05574400
Not Yet Recruiting
Phase 2
Intranasal insulin for prevention of perioperative delirium in femoral fracture surgery
Delirium
Prof Gideon A Caplan, The Prince of Wales Hospital216 enrolled1 locationACTRN12625000368437
Recruiting
Phase 1Phase 2
Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
hyperactive deliriumDelirium of Mixed Origin
Bruyère Health Research Institute.50 enrolled3 locationsNCT04824144
Not Yet Recruiting
Phase 2
Safety and feasibility of Intramuscular Dexmedetomidine for Delirium
Delirium
Monash Health60 enrolled4 locationsACTRN12625000103460
Recruiting
Phase 2Phase 3
The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients
Delirium
Sultan Qaboos University240 enrolled2 locationsNCT06509191
Terminated
Phase 2
A single centre pilot randomised controlled trial of enteral Guanfacine vs Quetiapine for agitated delirium in patients in the intensive care unit
Agitated delirium
Austin Hospital36 enrolled1 locationACTRN12624001075572
Recruiting
Phase 1Phase 2
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Emergence Delirium
Cairo University46 enrolled2 locationsNCT06545890
Recruiting
Phase 2
SLeep Evaluation and Effectiveness Protocol for Intensive Care Units (SLEEP-ICU)
Delirium
South Metropolitan Health Service100 enrolled3 locationsACTRN12624000991516
Recruiting
Phase 2Phase 3
The PREVENT AGITATION Trial II - Children ≤1 Year
Emergence Delirium
Rigshospitalet, Denmark336 enrolled1 locationNCT05091242
Not Yet Recruiting
Phase 2
A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive delirium
hyperactive delirium
Royal Melbourne Hospital1,200 enrolled3 locationsACTRN12622001532796
Terminated
Phase 2
Improving sleep in Intensive Care
ICU delirium
University of Queensland80 enrolled1 locationACTRN12620000661976
Active
Phase 2Phase 3
Melatonin for Delirium Reduction, Resolution And Mitigation of Abnormal Arousal (MelaDRRAMAA)
Delirium
Royal Melbourne Hospital120 enrolled1 locationACTRN12619000034134
Completed
Phase 2
Dexmedetomidine in delirium at the end of life
Delirium at the end of life
Illawarra Shoalhaven Local Health District22 enrolled1 locationACTRN12618000658213
Completed
Phase 2
Intranasal insulin for treatment of delirium.
Delirium
A/Prof Gideon A Caplan100 enrolled1 locationACTRN12618000318280